Characteristic features of intracellular pathogenic Leptospira in infected murine macrophages.

Authors:
Address: Department of Molecular Bacteriology and Immunology, Graduate School of Medicine, University of the Ryukyus, Nishihara, Okinawa 903-0125, Japan. claudia@med.u-ryukyu.ac.jp
Journal:


Publication:

abstract

Leptospira interrogans is a spirochaete responsible for a zoonotic disease known as leptospirosis. Leptospires are able to penetrate the abraded skin and mucous membranes and rapidly disseminate to target organs such as the liver, lungs and kidneys. How this pathogen escape from innate immune cells and spread to target organs remains poorly understood. In this paper, the intracellular trafficking undertaken by non-pathogenic Leptospira biflexa and pathogenic L. interrogans in mouse bone marrow-derived macrophages was compared. The delayed in the clearance of L. interrogans was observed. Furthermore, the acquisition of lysosomal markers by L. interrogans-containing phagosomes lagged behind that of L. biflexa-containing phagosomes, and although bone marrow-derived macrophages could degrade L. biflexa as well as L. interrogans, a population of L. interrogans was able to survive and replicate. Intact leptospires were found within vacuoles at 24 h post infection, suggesting that bacterial replication occurs within a membrane-bound compartment. In contrast, L. biflexa were completely degraded at 24 h post infection. Furthermore, L. interrogans but not L. biflexa, were released to the extracellular milieu. These results suggest that pathogenic leptospires are able to survive, replicate and exit from mouse macrophages, enabling their eventual spread to target organs.

© 2011 Blackwell Publishing Ltd.



Related Articles
Replication or death: distinct fates of pathogenic Leptospira strain Lai within macrophages of human or mouse origin.
Innate Immun. 2010
Replication or death: distinct fates of pathogenic Leptospira strain Lai within macrophages of human or mouse origin.
Li S, Ojcius DM, Liao S, Li L, Xue F, Dong H, Yan J. Innate Immun. 2010 Apr; 16(2):80-92. Epub 2009 Jul 8.
Control of immunologically crossreactive leptospiral infection by administration of lipopolysaccharides from a nonpathogenic strain of Leptospira biflexa.
Microbiol Immunol. 2000
Control of immunologically crossreactive leptospiral infection by administration of lipopolysaccharides from a nonpathogenic strain of Leptospira biflexa.
Matsuo K, Isogai E, Araki Y. Microbiol Immunol. 2000; 44(11):887-90.
Isolation and characterization of Salmonella typhimurium and Yersinia pseudotuberculosis-containing phagosomes from infected mouse macrophages: Y. pseudotuberculosis traffics to terminal lysosomes where they are degraded.
Eur J Cell Biol. 1998
Isolation and characterization of Salmonella typhimurium and Yersinia pseudotuberculosis-containing phagosomes from infected mouse macrophages: Y. pseudotuberculosis traffics to terminal lysosomes where they are degraded.
Mills SD, Finlay BB. Eur J Cell Biol. 1998 Sep; 77(1):35-47.
Review New insights into the pathogenicity of leptospires: evasion of host defences.
New Microbiol. 2010
Review New insights into the pathogenicity of leptospires: evasion of host defences.
Cinco M. New Microbiol. 2010 Oct; 33(4):283-92.
Review Leptospirosis: aspects of innate immunity, immunopathogenesis and immune evasion from the complement system.
Scand J Immunol. 2011
Review Leptospirosis: aspects of innate immunity, immunopathogenesis and immune evasion from the complement system.
Fraga TR, Barbosa AS, Isaac L. Scand J Immunol. 2011 May; 73(5):408-19.

To top Home


Show map | Diseases | Vaccination | Chronic disease | Medicine | Pregnancy | Heat & Sunburn | Cold | Security | Useful tips | Faq | News

TraveldoctorOnline 2001 • Disclaimer webmaster

The contents within traveldoctoronline are presented only for informational purposes and cannot substitute for professional health care or any other medical treatment.All users of this website with health problems should be oblige always to consult their medical doctor before starting any treatment.